Estimates Revisions Fulcrum Therapeutics, Inc.

Stocks

Market Closed - Nasdaq 00:00:00 25/09/2026 +04			5-day change	1st Jan Change
3.785 ^USD	-0.66%		+0.40%	-66.53%

08-17	Slate Medicines, Inc. entered into an agreement and plan of merger to acquire Fulcrum Therapeutics, Inc. for $350 million in a reverse merger transaction.	CI
08-17	Fulcrum to merge with Slate in all-stock deal after drug setback	RE

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	1y. Revenue rev.	1y. EPS revision
FULCRUM THERAPEUTICS, INC.	-	-
LONZA GROUP AG
IQVIA HOLDINGS INC.
BEONE MEDICINES AG
REVOLUTION MEDICINES, INC.
CELLTRION, INC.
MEDPACE HOLDINGS, INC.
EUROFINS SCIENTIFIC SE
ASCENDIS PHARMA A/S			-
TEMPUS AI, INC.
Average
Weighted average by Cap.